Documents

Click on the link to view document, or to save document, right click on the link and choose
"Save Target As..."

STANZ offers full safety code for party pills.
STANZ Press Release 11 Feb 2007.

   

PROPOSED RESTRICTED SUBSTANCE REGULATIONS
STANZ has instructed Public Law Specialists, Chen Palmer, to draft Restricted Substances Regulations for submission to the Associate Minister of Health, Hon Jim Anderton, as he considers whether to reclassify BZP and related piperazines as a Class C drug or to retain as a Restricted Substance.

   

CODE OF PRACTICE FOR RESTRICTED SUBSTANCES
The Code of Practice for Restricted Substances is a voluntary code for any business or person that imports, manufactures, stores, distributes or sells any restricted substance .It covers Sale and Supply, Dosage, Labelling etc. The Code and the GMP are in addition to the requirements of the Misuse of Drugs Amendment Act and have been established to further the harm reduction objectives of the Act. It includes the Code of Good Manufacturing Practice for Restricted Substances which is modelled on the New Zealand Code of Good Manufacturing Practice for medicinal Products.

   

CODE OF GOOD MANUFACTURING PRACTICE FOR RESTRICTED SUBSTANCES (“GMP”)
The GMP works with the Code of Practice, it covers manufacturing standards etc.

 

 

Misuse of Drugs Amendment Bill
Once the new Bill had been through the Select Health Committee process, and then through Parliament, several changes were made. On 21st June 2005, it received Royal Assent, meaning that on behalf of Her Majesty the Queen, the Governor General signed off on the legislation and it became active. This version is the final version which is now an active part of New Zealand law.
   

Select Health Committee's report on Bill Number 3
The Select Health Committee's report on the new law was tabled on 23rd May 2005

   
Post Consultation Code of Practice
This is the Code of Practice developed by STANZ, it is a set of guidelines and standards for industry covering the manufacture, packaging, marketing and sale of Social Tonics.
   
Proposed Supplementary Order Paper to Misuse of Drugs Amendment Bill No. 3
This “SOP” is the proposed new legislation developed by the NZ government which would govern the way Social Tonics are sold. This document was produced for the purposes of discussion and consultation.
   
STANZ Submission to Select Health Committee on Supplementary Order Paper
STANZ submission to the Select Health Committee, outlining our thoughts on the proposed new law.
   
Expert Advisory Committee on Drugs report on Benzylpiperazine
The NZ government has a committee of experts advise government on new drugs, making recommendations for classification based on evidence of harm. Here is their report on BZP.
   
Food Administration in New Zealand
NZ’s Food Safety Authority produced this document outlining a risk management framework (referred to in Code of Practice)
   
Guidelines for Safe Dance Parties (the big book)
NZ’s Ministry of Health produced this book of guidelines for safe dance parties, focussing on harm reduction. (referred to in Code of Practice)
   
STANZ letter to Retailers 14/4/2004
STANZ write to retailers urging them to adopt an R18 policy on all Social Tonics.
   
DEA Error relating to BZP
The USA DEA based their decision to prohibit BZP on faulty evidence, overestimating the potency of BZP by up to 40,000%. After this open letter, and communications through diplomatic channels, they admitted their mistake, but kept their prohibition.